Oramed Pharmaceuticals SG&A Expense (TTM) Analysis

Oramed Pharmaceuticals Inc (ORMP)

2.36 -0.04 (-1.87%) USD | NASDAQ | Oct 04, 16:00

2.36 0.00 (0.00%) After-Hours: 19:16

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2006. Upgrade now.

Date	Value
June 30, 2024	7.523M
March 31, 2024	8.474M
December 31, 2023	8.138M
September 30, 2023	9.171M
June 30, 2023	10.76M
March 31, 2023	11.03M
December 31, 2022	15.66M
September 30, 2022	14.84M
June 30, 2022	13.57M
March 31, 2022	11.95M
November 30, 2021	7.534M
August 31, 2021	5.937M
May 31, 2021	4.418M
February 28, 2021	4.151M
November 30, 2020	3.878M
August 31, 2020	4.232M
May 31, 2020	4.328M
February 29, 2020	4.197M
November 30, 2019	3.871M
August 31, 2019	3.722M
May 31, 2019	3.929M
February 28, 2019	4.073M
November 30, 2018	3.999M
August 31, 2018	4.083M
May 31, 2018	3.985M

Date	Value
February 28, 2018	3.447M
November 30, 2017	3.307M
August 31, 2017	2.759M
May 31, 2017	2.443M
February 28, 2017	2.493M
November 30, 2016	2.372M
August 31, 2016	2.452M
May 31, 2016	2.578M
February 29, 2016	2.742M
November 30, 2015	2.55M
August 31, 2015	2.602M
May 31, 2015	2.742M
February 28, 2015	2.837M
November 30, 2014	2.811M
August 31, 2014	2.629M
May 31, 2014	2.427M
February 28, 2014	2.112M
November 30, 2013	2.111M
August 31, 2013	2.032M
May 31, 2013	1.750M
February 28, 2013	1.541M
November 30, 2012	1.260M
August 31, 2012	1.203M
May 31, 2012	1.107M
February 29, 2012	1.166M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

3.871M

Minimum

Nov 2019

15.66M

Maximum

Dec 2022

8.087M

Average

7.534M

Median

Nov 2021

SG&A Expense (TTM) Benchmarks